Hydrocortamate
From Wikipedia, the free encyclopedia
Chemical compound
Pharmaceutical compound
| Clinical data | |
|---|---|
| Trade names | Magnacort, Ulcort |
| Other names | 11β,17α-Dihydroxy-3,20-dioxopregn-4-en-21-yl N,N-diethylglycinate |
| Routes of administration | Topical |
| Pharmacokinetic data | |
| Excretion | Hepatic |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| PubChem SID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.877 Edit this at Wikidata |
| Chemical and physical data | |
| Formula | C27H41NO6 |
| Molar mass | 475.626 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Hydrocortamate (brand names Magnacort, Ulcortis) is a synthetic glucocorticoid with anti-inflammatory and immunosuppressive properties.[1] [2] It is used topically to treat inflammation due to corticosteroid-responsive dermatoses.[3]
References
[edit ]- ^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 317–. ISBN 978-1-4757-2085-3.
- ^ Index Nominum 2000: International Drug Directory. Taylor & Francis. 2000. pp. 524–. ISBN 978-3-88763-075-1.
- ^ DrugBank DB00769